Names and pronunciation
(nye-rap′-a-rib) Zejula
PDF page 954
Drug reference
(nye-rap′-a-rib) Zejula
PDF page 954
Func. class.: Antineoplastic
PDF page 954
USES: Recurrent epithelial ovarian, fal- lopian tube, or primary peritoneal cancer
PDF page 954
DOSAGE AND ROUTES • Adult: PO 200 mg/day until disease progression or unacceptable toxicity. Begin therapy no later than 12 wk after last platinum-containing regimen
PDF page 954
Available forms: Capsule 100 mg
PDF page 954
• Adult: PO 200 mg/day until disease progression or unacceptable toxicity. Begin therapy no later than 12 wk after last platinum-containing regimen
PDF page 954